Hi — I handle bulk & wholesale for this oil. Ask me anything, or tap a question below.
What the research says
More than a scent. And we cite every word.
People reach for Cinnamon Bark for more than one thing. Here’s what the published studies actually found — graded honestly, each one linked.
9
uses studied
97
papers cited
0
hidden from you
What the published studies found
Early evidence · 82 studies
Fungal Infection
Available evidence for Cinnamon Bark against fungal infection consists almost entirely of in-vitro antifungal susceptibility studies (e.g., against Candida albicans, Aspergillus spp., Penicillium spp.) showing inhibitory activity, with no human clinical trials identified.
All available evidence is limited to in-vitro antimicrobial studies showing cinnamon bark (Cinnamomum zeylanicum/verum) and its combinations (e.g., with vetiver) inhibit acne-associated bacteria like P. acnes and S. epidermidis, but no human clinical trials for acne treatment were found.
The search returned mostly unrelated studies (e.g., animal semen cryopreservation); only a general phytochemical review mentions cinnamon bark's constituents (cinnamaldehyde, eugenol) as having reported 'anti-anxiety and antidepressant' properties without citing direct clinical trials on anxiety/stress in humans.
Evidence for Cinnamon Bark oil in burns/wound healing is limited to a general phytochemical review noting 'wound healing' among many pharmacological activities attributed to Cinnamomum verum compounds, with no dedicated clinical or in-vivo wound-healing studies identified; an ethnobotanical paper only tangentially mentions wound healing in a different plant (Sphagneticola trilobata), not cinnamon itself.
Only in-vitro/computational studies exist showing Cinnamomum zeylanicum extracts and phytochemicals have antimicrobial activity against dandruff-associated microbes (Malassezia furfur, P. acnes, S. epidermidis) and in silico inhibition of a bacterial cell division protein; no human clinical trials for dandruff treatment were found.
Evidence is limited to in-vitro studies showing cinnamon bark extract components (cinnamaldehyde, 2-methoxycinnamaldehyde) inhibit RANKL-induced osteoclastogenesis relevant to bone/joint pathology, plus a general narrative review mentioning anti-inflammatory and arthritis-related properties without clinical trial data.
One RCT found topical cinnamon ointment reduced perineal pain after episiotomy (not muscle pain specifically), and one preclinical study isolated analgesic diterpenoids from cinnamon bark showing effects in animal pain models; neither directly studied muscle pain in humans.
One randomized double-blind placebo-controlled trial found that oral cinnamon supplementation (600mg capsules, not essential oil, taken orally) significantly reduced migraine frequency, severity, and duration, along with reducing inflammatory markers IL-6 and NO in migraine patients.
One in-vitro study tested Cinnamomum zeylanicum (cinnamon bark) essential oil among several plant oils for antimelanogenic and enzyme-inhibitory effects, but cinnamon bark itself showed only modest alpha-glucosidase inhibition and was not among the oils with notable antimelanogenic (anti-hyperpigmentation) activity, unlike citrus oils in the same study.
